Denali Therapeutics Inc. (DNLI) PT Raised to $45 at Jefferies
Tweet Send to a Friend
Jefferies analyst Michael Yee raised the price target on Denali Therapeutics Inc. (NASDAQ: DNLI) to $45.00 (from $40.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
